Cancer Drugs Will Follow AIDS “Cocktail” Model, ASCO Researchers Say
Executive Summary
Cancer treatment will start following the HIV "cocktail" model, researchers said at the American Society of Clinical Oncology annual meeting in New Orleans
You may also be interested in...
Roche Sees Challenge In Cancer Drug Combos; Does Data Support Price?
Roche expects to face an upcoming challenge in defining the appropriate pricing model for the next generation of combination cancer therapies
Roche Sees Challenge In Cancer Drug Combos; Does Data Support Price?
Roche expects to face an upcoming challenge in defining the appropriate pricing model for the next generation of combination cancer therapies
Chiron Tifacogin Needs One Pivotal Study For Community Acquired Pneumonia
Chiron will need only a single pivotal trial for approval of its tissue factor pathway inhibitor tifacogin as a treatment for severe community acquired pneumonia